ONCOSPIRE GENOMICS
DEAD

Serial Number

85959163

Owner

Oncospire Genomics, LLC

Attorney

Angela C. Wilcox

Filing Date

Jun 13, 2013

Add to watchlist:

No watchlists yet
View on USPTO

ONCOSPIRE GENOMICS Trademark

Serial Number: 85959163

ONCOSPIRE GENOMICS is a trademark filed by Oncospire Genomics, LLC on June 13, 2013. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Oncospire Genomics, LLC

200 First Street SW
Rochester, MN 55905

Entity Type: 16

Trademark Details

Filing Date

June 13, 2013

Registration Date

Not Registered

Published for Opposition

January 21, 2014

Goods & Services

Medical testing for diagnostic or treatment purposes in the field of cancer research; medical diagnostic testing, monitoring and reporting services; medical evaluation services; medical monitoring services; medical diagnostic, prognostic and theranostic screening and testing; collection and preservation of DNA for medical purposes; consulting services in the field of healthcare and cancer diagnoses; providing a website featuring health and healthcare information related to cancer research, testing and screening; genetic testing for medical purposes; genetic testing for medical diagnostic purposes; genomic testing for medical purposes; providing information in the field of cancer prevention, screening, diagnosis and treatment; genetic testing for medical diagnostic purposes; genomic testing for medical diagnostic purposes

Medical and scientific research and development in the field of human disease; medical and scientific laboratory services; consulting services in the field of research, development and laboratory testing in the field of human disease; genetic research and development services; genetic testing services for research purposes; genomic research and development services; genomic testing services for research purposes; DNA screening for scientific research purposes; medical and scientific research, development and consulting in the field of oncology; medical and scientific research in the field of genetics and genetic engineering; medical and scientific research and consulting in the fields of genomics and generation sequencing; medical and scientific research in the field of cancer treatment and diagnosis; data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; conducting clinical trials for others; retrieval and correlation of genomic data; medical and scientific research relating to the design and development of cancer treatment therapies; conducting clinical and pre-clinical trials; diagnostic services in the field of molecular science, comparative genome analysis, DNA arrays and screening of nucleic acids; research and development of identification and treatment methods for hereditary factors leading to disease; identification of target molecules for cancer treatment; proteogenomic profiling; DNA-sequencing for scientific research purposes; targeted pharmaceutical drug development services; genotyping; gene screening; gene isolation and gene expression analysis for research or analysis purposes; gene mapping; gene analysis and biomarker discovery for research or analysis purposes; providing a website featuring information related to cancer research

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Apr 24, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 24, 2017 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 29, 2016 EXRA
SOU EXTENSION 5 GRANTED
Sep 28, 2016 EX5G
SOU EXTENSION 5 FILED
Sep 12, 2016 EXT5
SOU TEAS EXTENSION RECEIVED
Sep 12, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 23, 2016 EXRA
SOU EXTENSION 4 GRANTED
Apr 22, 2016 EX4G
SOU EXTENSION 4 FILED
Mar 18, 2016 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 18, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 12, 2015 EXRA
SOU EXTENSION 3 GRANTED
Sep 11, 2015 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 10, 2015 AITU
SOU EXTENSION 3 FILED
Aug 31, 2015 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 31, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 13, 2015 EXRA
SOU EXTENSION 2 GRANTED
Feb 11, 2015 EX2G
SOU EXTENSION 2 FILED
Feb 11, 2015 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 11, 2015 EEXT
ASSIGNED TO EXAMINER
Oct 22, 2014 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 23, 2014 EXRA
SOU EXTENSION 1 GRANTED
May 21, 2014 EX1G
SOU EXTENSION 1 FILED
May 21, 2014 EXT1
SOU TEAS EXTENSION RECEIVED
May 21, 2014 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 18, 2014 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 21, 2014 NPUB
PUBLISHED FOR OPPOSITION
Jan 21, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 13, 2013 PREV
ASSIGNED TO LIE
Dec 10, 2013 ALIE
ASSIGNED TO LIE
Nov 30, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 5, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 5, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 5, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 5, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 5, 2013 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 24, 2013 GNRN
NON-FINAL ACTION E-MAILED
Sep 24, 2013 GNRT
NON-FINAL ACTION WRITTEN
Sep 24, 2013 CNRT
ASSIGNED TO EXAMINER
Sep 24, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 21, 2013 NWOS
NEW APPLICATION ENTERED
Jun 17, 2013 NWAP